# NRG Oncology Network Group Operations Center

> **NIH NIH U10** · NRG ONCOLOGY FOUNDATION, INC. · 2022 · $3,272,505

## Abstract

NRG Clinical Trials Development Core Abstract 
The NRG Oncology (NRG) Clinical Trials Development Core (Core) provides the scientific 
leadership and infrastructure necessary to support the group's research activities and initiatives. 
NRG has a robust facility for clinical trials development, led by physician-investigators, 
statisticians, and administrative directors who possess an outstanding quantity and quality of 
knowledge and expertise in designing and directing complex, multicenter clinical trials that 
reflect the specific aims of the group. The Core works closely with the NRG's Statistics and 
Data Management Center, the NRG Data Monitoring Committee (DMC), and the NRG 
Administrative Core in soliciting, reviewing, approving, and developing prospective clinical trials. 
The program is committed to developing clinical trials that are congruent with NRG's and NCI's 
mission to implement high-quality clinical and translational trials (primarily late phase trials) in a 
timely manner. To that end, the Core investigators and staff work closely with NCI-CTEP, the 
NCTN's centralized functions (e.g., CTSU, CIRB) and the other NCTN Groups. Patient 
advocates and attention to diversity are included in the Core's functions. NRG's clinical trials 
development program is led by its Research Strategy Committee, whose members are 
internationally recognized chairs and vice-chairs of NRG's cancer disease site and other 
scientific committees who have great experience in institutional and network group research. 
The leaders and core members of these committees understand the importance of protocol 
development, new investigator training/mentorship, trial conduct, completion and timely analysis 
and publication of study results. These physician investigators and the Core administrative staff 
are well aligned with the overall mission of the NCTN and the continued success of NRG 
Oncology.

## Key facts

- **NIH application ID:** 10378671
- **Project number:** 5U10CA180868-09
- **Recipient organization:** NRG ONCOLOGY FOUNDATION, INC.
- **Principal Investigator:** NORMAN WOLMARK
- **Activity code:** U10 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $3,272,505
- **Award type:** 5
- **Project period:** 2014-04-17 → 2025-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10378671

## Citation

> US National Institutes of Health, RePORTER application 10378671, NRG Oncology Network Group Operations Center (5U10CA180868-09). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10378671. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*